Characteristics of hemp (Cannabis sativa L.) seed oil

Food Research Program, Agriculture and Agri-Food Canada, Pacific Agri-Food Research Centre, Summerland, British Columbia V0H 1Z0, Canada; E.N.S.A.M., École Nationale Superieure Agronomique de Montpellier, 2, Place Pierre Viala, 34060 Montpellier Cedex 1, France
Food Chemistry (Impact Factor: 3.33). 01/2002; 76:33-43. DOI: 10.1016/S0308-8146(01)00245-X

ABSTRACT Characteristics of oil extracted from hempseeds subjected to microwave treatments were evaluated. Microwave treatment improved oil yield, increased carotenoid and other pigment contents and decreased p-anisidine value without significant changes in other properties. Hempseed oil showed absorbance in the UV-B and UV-C ranges with potential for use as a broad spectrum UV protectant. [beta]-Tocopherol concentrations increased, while the major tocopherol, [gamma]-tocopherol, and fatty acid composition of the oil were unaffected by microwave treatment of hempseed. Hempseed oil showed high kinetic stability during heating and cooling, as characterized by differential scanning calorimetry (DSC). Microwave treatment shifted the melting range of oils to lower temperatures and increased oxidation temperatures, suggesting increased protective effect upon heating.

  • Source
    Dataset: ata2006204
    [Show abstract] [Hide abstract]
    ABSTRACT: 119 Annales de Toxicologie Analytique, vol. XVIII, n° 2, 2006 RÉSUMÉ La présente étude porte sur la caractérisation de la compo-sition lipidique de l'huile des graines de Cannabis sativa L. type drogue cultivé au Nord du Maroc. Les résultats obtenus montrent que la composition en acides gras de cette huile est assez proche de celle des huiles de graines de cannabis type fibre cultivé dans d'autres parties du monde. Un taux d'aci-de linolénique (oméga-3) de 16 %, un ratio pondéral acides poly-insaturés/acides saturés (P/S) de 6:1 et un rapport oméga-6/oméga-3 de 3:1, ont été déterminés. Les teneurs de cette huile en stérols et en tocophérols (α, β, γ) ont été évaluées respectivement à 3765 mg /kg, 13 mg/kg, 2 mg/kg et 426 mg/kg. Cette composition en acides gras, sté-rols et tocophérols, présente de fortes similitudes avec celle de l'huile de soja. Enfin, un lavage à l'hexane des graines avant extraction de l'huile, permet d'obtenir un produit pratiquement exempt de traces de Δ-9-THC. MOTS-CLÉS
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The impact of the Western diet on chronic diseases, such as cancer, has been well recognized. Dietary saturated and trans fatty acids have been found to play a negative role in obesity, heart disease, diabetes and cancer, while the beneficial health effects of n-3 polyunsaturated fatty acids (n-3 PUFAs) have become widely accepted. Despite the current knowledge, n-3 PUFA intake is still under recommended daily intake levels in Europe. As wild fish, currently still the major source of n-3 PUFA, are facing a decline, alternative sources such as marine and plant (both natural and transgenic) sources are being explored. In this review we aim to provide an overview of the current biological sources of n-3 PUFAs, their part in normal physiology, as well as their emerging application in supportive cancer care, and more specifically in cancer cachexia, therapy-related neurocognitive dysfunction and distress. In addition, we provide a brief summary of currently ongoing clinical trials examining potential beneficial effects of n-3 PUFAs in reducing cancer(therapy)-related side effects, and describe future research directions.
    Phytochemistry Reviews 03/2014; 13(1):223-244. · 4.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cannabidiol (CBD), a once-considered inert cannabis constituent, is one of two primary constituents of cannabis, alongside delta-9-tetrahydrocannabinol (∆9-THC/THC). In the last 30 years, CBD has become implicated with a range of pharmaceutical mechanisms of great therapeutic interest and utility. This review details the literature speculating CBD’s attenuation of psychotic symptoms, particularly in light of a marked elevation in mean THC concentrations, and a concomitant decline in CBD concentrations in the prevalent U.K street market cannabis derivatives since c. 2000. CBD is purported to exhibit pharmacology akin to established atypical antipsychotics, whilst THC has been implicated with the precipitation of psychosis, and the induction of associated symptoms. The aim of the review was to clarify the conjecture surrounding CBD’s antipsychotic efficacy, before going on to detail prominent theories about its associated pharmacodynamics. Were CBD’s antipsychotic efficacy established, then there is potential for major latent anthropological repercussions to manifest, such as significant elevations in psychosis manifestations in the U.K. The review found a largely affirmative body of evidence asserting CBD’s antipsychotic efficacy. CBD exhibited capacity to attenuate natural and artificially induced psychoses in both animal and human cohorts, the latter of which included individuals considered resistant to conventional treatment. CBD also shows promising potential for use as an antipsychotic drug for Parkinson’s disease (PD) patients with psychosis, owing to its low rate of extra-pyramidal side-effect induction. A range of potential pharmacological mechanisms behind CBD’s neuroleptic pharmacology are outlined, with particular emphasis on its prevention of the hydrolysis and reuptake of the endogenous cannabinoid, anandamide. However, given the nebular aetiological basis for psychoses, explicit conclusions on how CBD attenuates psychotic symptoms remains to be determined.
    2321–7235. 10/2013; 1(2):113-147.


Available from
Jun 3, 2014